The Global Vaccines Innovation and Immunology Conference highlights the essential role of manufacturing science in delivering safe, scalable, and high-quality vaccines worldwide.
🧪 From Lab to Global Supply
CMC (Chemistry, Manufacturing, and Controls) ensures that vaccine candidates
are transformed into reliable and reproducible products. Effective
bioprocessing strategies are critical for maintaining quality, consistency, and
regulatory compliance throughout development.
🔍 Key Focus Areas
• Upstream and downstream bioprocessing
• GMP manufacturing standards
• RNA, vector, and subunit vaccine production
• Formulation, stabilization & lyophilization
• Analytical characterization and quality control
• Scaling from lab to commercial manufacturing
⚙️
Advancing Manufacturing Technologies
Modern vaccine production leverages automation, robotics, and smart
biomanufacturing systems to enhance efficiency and precision. Single-use
technologies and modular facilities improve flexibility while reducing
contamination risks.
Robust manufacturing systems ensure consistent vaccine supply, support rapid scale-up during public health emergencies, and enable equitable global distribution.
🌐 Conference Details
📅
September 21–23, 2026
📍
London, United Kingdom & Online
📄 Submit Your Abstract
https://vaccines.miconferences.com/abstract-submission
🔗 Event Website
https://vaccines.miconferences.com/
#GVX2026 #Bioprocessing #VaccineManufacturing #GMP #Biotechnology #HealthcareInnovation #GlobalHealth
No comments:
Post a Comment